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Introduction
Selecting the strategy for isolation of constituents from plant extracts and other natural sources is of utmost importance with respect to the outcome as well as time and efforts spent on discovery of pharmacologically active natural products. Prior to preparativescale isolation, it is convenient to gain as much knowledge as possible about chemical entities present, both in order to make qualified decisions about worthwhileness of isolation of a particular constituent, and to choose optimal isolation methodology. Although some information about extract constituents can be obtained from thin layer chromatography combined with the use of compound class-specific spray reagents, by gas chromatography combined with mass spectrometry (MS), and by high-performance liquid chromatography (HPLC) combined with photo-diode array detection (PDA) or MS, all these techniques suffer from the limited structural information they provide as compared to nuclear magnetic resonance (NMR) spectroscopic techniques.
Within recent years, hyphenation of HPLC, PDA, MS, and solidphase extraction (SPE), with NMR spectroscopy (HPLC-PDA-MS-SPE-NMR) has emerged as an attractive analytical technique for fast and reliable dereplication of crude plant extracts (Jaroszewski, 2005a,b; Staerk et al., 2006; . This technique has been used for identification of known compounds as well as for rigorous structure elucidation of new natural products directly from crude extracts. Examples include sesquiterpene lactones (Lambert et al., 2007) , quinic acid derivatives (Sprogøe et al., 2007) , diterpenes and caffeoyl glycosides (Clarkson et al., 2006a (Clarkson et al., , 2006b , flavonoid glycosides (Clarkson et al., 2005; Exarchou et al., 2006; Tatsis et al., 2007) , cardenolide glycosides (Clarkson et al., 2005) , isoflavonoids (Lambert et al., 2005a) , and alkaloids (Bieri et al., 2006; Lee et al., 2007; . One advantage of the HPLC-SPE-NMR technique compared to direct HPLC-NMR methods (Albert, 2002; Jaroszewski, 2005a) is the possibility of linear analyte accumulation by repetitive adsorption on SPE cartridges (Clarkson et al., 2006a; Lambert et al., 2005a, b) . Subsequent elution of the analyte with a deuterated organic solvent, resulting in focusing of the analyte in the detection cell, adds further increase in sensitivity of this hyphenated NMR technique (Jaroszewski, 2005b; Staerk et al., 2006) . Here, we describe application of HPLC-PDA-MS-SPE-NMR to fast dereplication of an extract of aerial parts of Haplophyllum acutifolium, which showed activity (IC 50 < 12 lg/ml) in our in vitro Plasmodium falciparum toxicity screening assay.
Haplophyllum from the Mediterranean parts of Europe and Africa to Eastern parts of Siberia. Around 30 of these species are represented in Iran, 14 of which are endemic to the country. Haplophyllum is known as a rich source of quinoline alkaloids, and several phytochemical investigations of different species have been reported in recent years (Michael, 2008) , including investigations of H. acutifolium collected in Turkmenistan (Razzakova et al., 1975 (Razzakova et al., , 1986 , and references cited therein). Extracts of various Haplophyllum species are used in traditional medicine as analgesics, antispasmodics, diuretics, and sedatives, as well as topical agents against skin diseases (Nazrullaev et al., 2001) . Quinolinone alkaloids isolated from Haplophyllum and other Rutaceous species have shown estrogenic (Nazrullaev et al., 2001) , antifungal (Cantrell et al., 2005) , antialgal (Cheng et al., 2005) , antiviral (Cheng et al., 2005) , antibacterial (Hanawa et al., 2004) , and antiparasitic activity (Michael, 2003) . In spite of the existence of an abundant literature about quinolinone alkaloids of Haplophyllum, dereplication of the extract of H. acutifolium using HPLC-PDA-MS-SPE-NMR allowed fast identification of several previously unknown minor alkaloids present in the plant.
Results and discussion
HPLC-PDA-MS-SPE-NMR experiments with crude ethyl acetate extract of aerial parts of H. acutifolium (crude extract A, see Section 4) were performed using UV trace at 235 nm for threshold-based adsorption of constituents on SPE cartridges containing poly(divinylbenzene)-based resin (Clarkson et al., 2007) . Four or six repetitive trappings of material eluted in peaks 1-9 ( Fig. 1 ) were performed. The trapped compounds were subsequently eluted with CD 3 CN for acquisition of NMR data. This led to identification of five new and two already known 4-quinolinone alkaloids (1, 2a, 3, 4, 6, 8, and 9) along with a tricyclic hemiterpenoid alkaloid haplamine (5) and the lignan 7 as detailed below; the identified structures ( Fig. 2) are numbered according to elution order of the HPLC peaks ( Fig. 1 ). Parallel HPLC-PDA-MS-SPE-NMR experiments with an alkaloid-enriched fraction (fraction III from crude extract B, see Section 4) showed the existence of one additional, new quinolinone alkaloid (2b) as a minor constituent.
The constituent eluted as peak 1 (compound 1) was assigned the molecular formula C 18 H 21 NO 2 as determined by off-line HRE-SIFTMS. The 1 H NMR spectrum acquired in the HPLC-SPE-NMR mode showed the presence of a 1,2-disubstituted benzene with a characteristic downfield shift of H-5 (d 8.11, J 5-6 = 8.0 Hz and J 5-7 = 1.4 Hz) attributable to a peri-oriented carbonyl group, a one-proton singlet of H-3 (d 5.98), and a broad singlet of H-1 (d 9.55). This information, together with 1 H-1 H correlations for H-5, H-6, H-7, and H-8 found in a COSY spectrum and 13 C NMR reso-nances identified in a HSQC spectrum, both acquired in the HPLC-SPE-NMR mode, proved the presence of a 2-substituted 4quinolinone moiety. In the COSY spectrum, a spin system corresponding to a (3Z,5E)-7-hydroxynona-3,5-dien-1-yl moiety was observed. The configuration of the two conjugated double bonds was determined by analysis of the coupling patterns of H-3 0 and H-4 0 (H-3 0 : d 5.44, dt, J 3 0 -4 0 = 10.4 Hz, J 2 0 -3 0 = 7.7 Hz; H-4 0 : d 6.03 br t, J 3 0 -4 0 % J 4 0 -5 0 % 11.1 Hz) and of H-5 0 and H-6 0 (H-5 0 : d 6.45, ddt, J 5 0 -6 0 = 15.2 Hz, J 4 0 -5 0 = 11.2 Hz, J 5 0 -7 0 = J 3 0 -5 0 = 1.2 Hz; H-6 0 : d 5.62, dd, J 5 0 -6 0 = 15.2 Hz, J 6 0 -7 0 = 6.3 Hz) as Z and E, respectively. The hydroxylation of C-7 0 was established by HSQC correlation of the 13 C resonance at d 73.7 with H-7 0 (d 3.90), identified by its COSY correlations. Preparative-scale isolation afforded 4 mg of 1, which showed no optical rotation. Since chiral allylic alcohols and 2,4diene-1-ols display appreciable specific rotation at the sodium Dline (Airs et al., 1942; Burgess and Jennings, 1991; Takaishi et al., 1991; Tsai et al., 2001) , it is concluded that 1 isolated from H. acutifolium is a racemate. Compound 1 is a new alkaloid for which the name haplacutine A is suggested.
The material eluted with peak 2 (compound 2a) was assigned the molecular formula C 18 H 21 NO 2 as determined by off-line HRE-SIFTMS. Based on the 1 H NMR and COSY spectra acquired in the HPLC-SPE-NMR mode, it contained a 4-quinolinone moiety and a spin system corresponding to a 3-hydroxynona-4,6-dien-1-yl moiety. The configuration of the C-4 0 -C-5 0 double bond was established as E (H-4 0 : d 5.70, br dd, J 4 0 -5 0 = 15.2 Hz, J 3 0 -4 0 = 6.4 Hz; H-5 0 : d 6.53, ddt, J 4 0 -5 0 = 15.2 Hz, J 5 0 -6 0 = 11.1 Hz, J 5 0 -7 0 = J 3 0 -5 0 = 1.2 Hz) and that of the C-6 0 -C-7 0 double bond as Z (H-6 0 : d 5.95, m; H-7 0 : d 5.44, dt, J 6 0 -7 0 = 10.8 Hz, J 7 0 -8 0 = 7.5 Hz). When the HPLC-PDA-MS-SPE-NMR analysis was performed with the corresponding peak of an alkaloid-enriched fraction of the extract (fraction III obtained from crude extract B, see Section 4), 2a was accompanied by a closely related analogue 2b (approximately 60% relative to the major constituent 2a as determined from the integrals of the 1 H NMR resonances, see Supplementary Fig. 3 ). The configuration of both double bonds in the minor constituent was E (H-4 0 : d 5.61, dd, J 4 0 -5 0 = 15.3 Hz, J 3 0 -4 0 = 6.6 Hz; H-5 0 : d 6.20, dd, J 4 0 -5 0 = 15.3 Hz, J 5 0 -6 0 = 10.6 Hz; H-6 0 : d 6.05, dd, J 6 0 -7 0 = 15.3 Hz, J 5 0 -6 0 = 10.6 Hz; H-7 0 ; d 5.75, dt, J 6 0 -7 0 = 15.3 Hz, J 7 0 -8 0 = 6.6 Hz). Thus, 2a and 2b are stereoisomers, and they are both new compounds for which the names haplacutine B and haplacutine C, respectively, are suggested. In the crude extract A, 2b was undetectable, and therefore 2b co-eluting with 2a in the alkaloid-enriched fraction III may be an artefact formed by acid-catalyzed, free-radical or photochemical isomerization of 2a or by an allylic-type rearrangement of 1.
The constituent eluted as peak 3 (compound 3) was assigned the molecular formula C 18 H 19 NO 2 (off-line HRESIFTMS). In addition to signals from a 4-quinolinone moiety, 1 H NMR and COSY spectra showed signals corresponding to an aliphatic A 2 X 2 spin system and a hexa-1,3-dien-1-yl moiety. The downfield shift of the signals of H-2 0 and H-5 0 (d 3.10 and 7.57, respectively) confirmed that the two moieties are connected by the C-3 0 carbonyl group. Analysis of the coupling pattern of H-4 0 to H-7 0 (see Section 4.9) established the E-and Z-configuration of the C-4 0 -C-5 0 and C-6 0 -C-7 0 double bonds, respectively. Compound 3 is a new alkaloid for which the name haplacutine D is suggested.
The constituent eluted as peak 4 (compound 4) was assigned the molecular formula C 16 H 19 NO (HRESIFTMS), and the 1 H NMR spectrum showed signals corresponding to a 4-quinolinone moiety and a hept-4-en-1-yl moiety. The 1 H NMR data were in agreement with those reported for acutine, previously isolated from H. acutifolium (Razzakova et al., 1975) . Acutine was initially formulated as 2-(hept-4-enyl)quinolin-4(1H)-one (Gulyamova et al., 1974) without any information about the configuration of the double bond, but the coupling patterns observed for H-4 0 and H-5 0 in the present investigation (H-4 0 : d 5.38, dtt, J 4 0 -5 0 = 10.8 Hz, J 3 0 -4 0 = 7.1 Hz, J 4 0 -6 0 = 1.4 Hz; H-5 0 : d 5.44, dtt, J 4 0 -5 0 = 10.8 Hz, J 5 0 -6 0 = 7.1 Hz, J 3 0 -5 0 = 1.2 Hz) proved that compound 4, and thus acutine, is 2-[(4Z)hept-4-en-1-yl]quinolin-4(1H)-one.
Haplamine (5) was identified as the material eluted with peak 5. Although the coupling pattern observed for the three hydrogens of the aromatic ring system indicated the presence of a 1,2,4-trisubstituted benzene, the site of methoxylation (i.e., C-6 or C-7) could not be unambiguously assigned by comparison of the observed chemical shift values with those reported for haplamine (syn. 6-meth-oxyflindersine) (Campbell et al., 1990; Cantrell et al., 2005) and 7methoxyflindersine (Brader et al., 1996) . However, correlations found in a NOESY spectrum acquired in the HPLC-SPE-NMR mode (see Supplementary Fig. 1 ) proved methoxylation at C-6.
The constituent eluted as peak 6 (compound 6) was assigned the molecular formula C 18 H 21 NO (HRESIFTMS). This is in agreement with the presence of a 4-quinolinone moiety and a nona-3,6-dien-1-yl moiety, as confirmed by connectivities observed in a COSY spectrum. The Z-configuration of the C-6 0 -C-7 0 double bond was identified based on 1 H NMR coupling patterns (H-6 0 : d 5.20, dtt, J 6 0 -7 0 = 10.7 Hz, J 5 0 -6 0 = 7.3 Hz, J 6 0 -8 0 = 1.6 Hz; H-7 0 : d 5.31, dtt, J 6 0 -7 0 = 10.7 Hz, J 7 0 -8 0 = 7.2 Hz, J 5 0 -7 0 = 1.6 Hz), whereas the configuration of the C-3 0 -C-4 0 double bond was not immediately clear because H-3 0 and H-4 0 appeared as a multiplet (d 5.42). However, the simulated coupling pattern of H-3 0 and H-4 0 using J 3 0 -4 0 coupling constant corresponding to the Z-configuration was practically identical to the experimentally observed coupling pattern (simulation parameters: d Y-3 0 5.43, d Y-4 0 5.41, J 3 0 -4 0 = 10.7 Hz, J 4 0 -5 0 = 7.1 Hz, J 2 0 -3 0 = 6.8 Hz, J 2 0 -4 0 = J 3 0 -5 0 = 1.1 Hz), whereas simulated spectrum using an E coupling constant was distinctly different (data not shown; cf. however structure of 8 and Fig. 4 ). In addition, the observed chemical shifts of C-2 0 and C-5 0 (d 27.2 and d 26.0, respectively, obtained from a HSQC spectrum), were in agreement with the Z-configuration of the C-3 0 -C-4 0 double bond, whereas chemical shift values above d 30 would be expected for the E-configuration, as shown by chemical shift predictions and literature data (Ivanciuc et al., 1997) . Thus, compound 6 is formulated as 2-[(3Z,6Z)-nona-3,6-dien-1-yl]quinolin-4(1H)-one. Full assignment of all 1 H and 13 C NMR resonances was possible based on 1 H, COSY, HSQC, and HMBC experiments obtained in the HPLC-SPE-NMR mode. In order to illustrate the use of HPLC-SPE-NMR methodology, the HSQC and HMBC spectra used for assignment of 13 C resonances of 6 are shown in Fig. 3 . A compound with a similar structure has previously been isolated from Vepris ampody (Kan-Fan et al., 1970) . However, the authors were only able to identify the compound as either 2-(nona-3,6-dien-1-yl)quinolin-4(1H)one or 2-(nona-2,6-dien-1-yl)quinolin-4(1H)-one, and without any information about configuration of the double bonds. Later, Razzakova et al. (1986) isolated a constituent named 2-nonadie- Fig. 3 . Gradient-selected HSQC spectrum (left) and HMBC spectrum (right) of compound 6, allowing full assignment of all 13 C resonances in HPLC-SPE-NMR mode.
nyl-4-quinoline, but without any information about the position and configuration of the two double bonds. Compound 6 is therefore considered a new compound, for which the name haplacutine E is proposed.
The constituent eluted as peak 7 was identified as (+)-eudesmin (7) on the basis of 1 H NMR spectroscopic data recorded in HPLC-SPE-NMR mode (see Supplementary Fig. 2) , as well as the identity of 1 H and 13 C NMR data and optical rotation data (see Supplementary material) of isolated material with those previously reported (Iida et al., 1982; Miyazawa et al., 1995; Roy et al., 2002) . Eudesmine has previously been isolated from Haplophyllum species (Razzakova et al., 1972) .
The constituent eluted as peak 8 (compound 8) was assigned the molecular formula C 18 H 23 NO (HRESIFTMS), and the presence of a 4quinolinone moiety and a non-3-en-1-yl side chain was revealed by correlations in a COSY spectrum. The Z-configuration was proved by comparing the experimental coupling pattern of the double bond hydrogens with simulated spectra (Fig. 4) . This, and the chemical shift values of C-2 0 and C-5 0 (d 27.4 and d 27.7, respectively) , established the structure of 8 as 2-[(3Z)-non-3-en-1-yl]quinolin-4(1H)one, for which the name haplacutine F is proposed.
2-Nonylquinolin-4(1H)-one (9) was identified as the compound eluted as peak 9 based on HRESIFTMS data and comparison of 1 H NMR spectra with those reported in literature (Kostova et al., 1999) .
NMR and HRMS data for new compounds are reported in Section 4, whereas retention times, MS data, and NMR data for known compounds are shown in Supplementary Table 1 . The spectra of 5, 7 and 9 obtained in the hyphenation mode are shown in Supplementary Fig. 2 . No useful NMR data could be obtained from the remaining peaks. Preparative-scale fractionation of extract B of H. acutifolium, comprising a partitioning between chloroform and dilute acid, yielded compounds 1 and 4-7 in small amounts. However, since the H. acutifolium alkaloids are tautomeric amides, this standard procedure for alkaloid isolation was not effective, as highlighted by isolation of 6 from the chloroform fraction as well as from the acidic fraction (fractions I and III, respectively, see Section 4). It was not possible to isolate compound 2-3, 8, and 9 in satisfactory amounts and purity. The antiplasmodial activity of compounds 4 and 6 was assessed in an in vitro antiplasmodial toxicity assay. Compound 4 and 6 showed IC 50 values of 2.17 ± 0.22 lM and 3.79 ± 0.24 lM, respectively, whereas the corresponding value for chloroquine diphosphate was 32.8 ± 0.24 nM. Since 4-quinolone alkaloids generally exhibit numerous toxicological activities in the low micromolar range as described in the Introduction, the observed antiplasmodial activity presumably represents a general toxic effect.
Conclusion
In conclusion, this study demonstrated the fast and dependable dereplication of alkaloid constituents of crude extract of H. acutifolium by HPLC-PDA-MS-SPE-NMR. On-line analysis of nine peaks led to identification of six new and two known 4-quinolinone alkaloids as well as a hemiterpenoid 2-quinolinone alkaloid and a lignan. In agreement with earlier investigations of tautomeric equilibria between hydroxyquinolines and quinolinones in solution (de la Cruz et al., 1992; Mphahlele and El-Nahas, 2004; Tokay and Ögretir, 2002) , the alkaloids are formulated as quinolinones. The finding of six new 2-alkylquinolinones in extract of aerial parts of H. acutifolium shows that reinvestigation of plants with new and more sensitive technology can add considerable new phytochemical information to already well-investigated species. In continuation of the HPLC-PDA-MS-SPE-NMR investigation, two of the alkaloids were isolated and were shown to inhibit growth of malaria parasites in the low micromolar range. On the basis of this finding, the observed antiplasmodial activity of crude extract of H. acutifolium is concluded to represent combined effect of quinolinone alkaloids present in this plant.
Experimental

General
Optical rotations were measured using a Perkin-Elmer 241 polarimeter. NMR spectra of isolated compounds were recorded on a Bruker Avance 400 spectrometer (proton frequency 400.13 MHz) at 25°C, using TMS as internal standard. HRMS measurements were performed using a Bruker APEX Qe Fourier-transform mass spectrometer equipped with a 9.4 T superconducting cryomagnet and an external ESI source (Apollo II source). The spectra were externally calibrated with arginine cluster in positive and negative ion mode. The samples were dissolved in MeOH, further diluted in 50% MeOH with 0.2% HCOOH, and introduced into the ion source using a syringe pump with a flow of 2 ll/min. Preparative-scale HPLC separations were performed with a 250 Â 16 mm Lichrosorb RP18 (5 lm) column at a flow rate of 8 ml/min, using a chromatograph consisting of a Gynkotek P 580 pump, a Rheodyne 7725 injector, and a Shimadzu SPD-10AV spectrophotometric detector operating at 254 nm, or with a 250 Â 21.2 mm Luna 2 C18 (5 lm) column at a flow rate of 10 ml/min, using a Waters 590 pump, a Rheodyne 7125 injector, and a Lambda-Max Model 481 LC UV detector operating at 235 nm. Spin coupling pattern simulations were performed with gNMR ver. 4.1.2 software (Adept Scientific, Herts, UK). Chemical shift predictions were performed with ChemNMR software as implemented in ChemBioDraw Ultra ver. 11.0 (CambridgeSoft, Cambridge, UK). Fisch., Ruta perforata M. Bieb.] (Rutaceae) were collected on August 20, 2004, at a location 40 km west of Mashhad, Iran (altitude 1650 m) and identified by Mr. Ali Ahi. The plant material was dried immediately after collection and powdered before extraction. Voucher specimen (DFHJJ56) was deposited in Herbarium C (Botanical Museum, University of Copenhagen, Copenhagen, Denmark).
Plant material
Extraction and sample preparation
Extract A was prepared by macerating 117 g of the plant material with 3 Â 0.5 l of EtOAc, and the combined extracts were evaporated to dryness under reduced pressure to give 2.27 g of residue.
A small amount (7.5 mg) of extract A was used for HPLC-PDA-MS-SPE-NMR analysis by making solutions of 28 mg/ml in H 2 O-MeCN 2:7, and the rest was used for prep. HPLC. Extract B was prepared by extraction of 500 g of powdered material with 4 Â 1 l of EtOAc and evaporation.
HPLC-PDA-MS-SPE-NMR experiments
The HPLC-PDA-MS-SPE-NMR instrument consisted of an Agilent 1100 HPLC system (degasser, quaternary solvent delivery pump, autosampler, PDA detector), a Knauer K100 Wellchrom pump for post-column H 2 O delivery, a Spark Prospekt 2 solidphase extraction device, a Bruker EsquireLC mass spectrometer equipped with electrospray ionization (ESI) interface, and a Bruker Avance 600 NMR spectrometer equipped with a 30-ll inverse 1 H{ 13 C} flow-probe operating at 25°C. HPLC separations were performed at 40°C on a 150 Â 4.6 mm i.d., 3 lm particle size, Phenomenex Luna 2 C18 column, using mixtures of H 2 O-MeCN 95:5 + 0.1% HCOOH (eluent A) and H 2 O-MeCN 5:95 + 0.1% HCOOH (eluent B). The eluate from the column was split with an Acurate splitter, directing 5% of the flow to the mass spectrometer and 95% to the PDA detector. MS spectra were acquired in positiveion mode, using drying temperature of 350°C, nebulizer pressure of 15 psi, and drying gas flow of 15 ml/min. The HPLC solvent flow (0.8 ml/min) from the PDA detector was diluted with H 2 O (2 ml/ min) and directed to the SPE unit. GP phase [general-purpose poly(divinylbenzene)-based resin] SPE cartridges, 10 Â 2 mm i.d. from Spark Holland, were used for trapping of selected compounds based on UV absorption levels at 235 nm. Four cumulative trappings of analytes from separation of 1.4 mg of the raw extract per injection were performed using the following linear gradient elution profile: 0 min, 19% B; 20 min, 32.2% B; 30 min, 50% B; 50 min, 100% B; 60 min, 100% B; 62 min, 19% B, and 8 min conditioning with 19% B. Two extended separations, allowing separation of up to 2.8 mg extract per injection, were performed with four or six adsorptions using the following linear gradient elution profile: 0 min, 19% B; 30 min, 32.2% B; 40 min, 50% B; 60 min, 100% B; 70 min, 100% B; 72 min, 19% B, and 8 min conditioning with 19% B. Prior to use, the SPE cartridges were conditioned with 500 ll of MeCN at 6 ml/min and flushed with 500 ll H 2 O at 1 ml/min. After trapping, the cartridges were dried with a stream of dry N 2 gas for 45 min and the analytes eluted to the NMR flow cell with CD 3 CN. The HPLC-PDA-MS-SPE-NMR experiments were controlled with Bruker HyStar ver. 2.3 software. NMR data acquisition and processing were performed using Bruker XWINNMR ver. 3.1 software. After acquisition of NMR data, the samples were removed from the probe and subjected to HRESIFTMS analysis.
Preparative-scale isolation
Crude extract B was dissolved in 0.5 l of CHCl 3 and the solution extracted with H 2 O acidified to pH 2 with 1 M H 2 SO 4 (7 Â 0.5 l) to give fractions I (21 g) and II, respectively. Fraction II was alkalized to pH 11 with concentrated aq. NH 3 and extracted with CHCl 3 , which after concentration yielded 250 mg of fraction III. Fraction I was separated by isocratic prep. HPLC (Lichrosorb RP18, MeCN-H 2 O 6:4 + 0.1% TFA), resulting in fractions Ia (20.2 mg), Ib (32.7 mg), and Ic (108.6 mg). These fractions were re-chromatographed to yield 9.6 mg of 6 (Ia: MeCN-H 2 O 1:1 + 0.1% TFA), 27.6 mg of 5 (Ib: MeCN-H 2 O 4:6 + 0.1% TFA), and 18 mg of 7 (Ic MeCN-H 2 O 6:4 + 0.1% TFA). Fraction III was separated by isocratic prep. HPLC (Lichrosorb RP18, MeCN-H 2 O 6:4 + 0.1% TFA), resulting in fractions IIIa-IIIi. Fractions IIIf and IIIi were re-chromatographed using MeCN-H 2 O 1:1 + 0.1% TFA to yield 5 mg of 4 and 10 mg of 6, respectively. Extract A was subjected to targeted isolation of 1 by repeated prep. HPLC (Luna 2 C18, MeCN-H 2 O 22:78) to yield 4 mg of 1.
Antiplasmodial assay
Chloroquine-sensitive P. falciparum 3D7 strain was cultured in vitro using a modified method of Trager and Jensen (1976) , and quantitative assessment of antiplasmodial activity in vitro was performed as described in details elsewhere (Sairafianpour et al., 2001; Ziegler et al., 2002) .
